Pfizer (PFE) Tops Q1 EPS by 10c; Bumps EPS Outlook

Pfizer (NYSE: PFE) reported Q1 EPS of $0.85, $0.10 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.1 billion versus the consensus estimate of $12.99 billion.

GUIDANCE:

Pfizer raises midpoint of FY2019 EPS by 1 cent to $2.83-$2.93, versus the consensus of $2.89. Reaffirmed 2019 Financial Guidance for Revenues

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Pfizer executive says China now leads Europe in drug innovation
• Cerebras Q1 EPS miss sends shares down 9% after-hours